Multivalent Vaccine Composition for Broad Strain Coverage

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing vaccines against rapidly mutating pathogens often become obsolete due to antigen changes over time, requiring frequent updates and providing inconsistent protection.

Innovation Solution

Vaccines comprising a diverse set of antigens that represent a significant portion of clades and operational taxonomic units (OTUs) of a microbe, with controlled edit distances between antigens to ensure broad immune response coverage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If a single antigen is used in the vaccine, then the vaccine can be simple to manufacture, but the immune response becomes obsolete when antigens change over time

Engineering Contradiction:
Improvevaccine manufacturing simplicityVSAvoidimmune response effectiveness
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The vaccine is segmented into multiple antigen components, each representing different clades of the microbe. Instead of using a single antigen, the vaccine comprises a set of antigens (at least 2, 3, 4, or more) that collectively cover a broader range of microbial variants, ensuring the immune system is primed against multiple possible strains simultaneously.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The vaccine achieves multi-functionality by incorporating antigens that represent at least 60% of fifth order clades or at least 60% of all operational taxonomic units (OTUs) of the microbe. This universal approach allows a single vaccine formulation to provide protection against diverse strains without requiring frequent updates.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If antigens are updated frequently to match circulating strains, then the immune response remains effective, but the vaccine requires periodic reconfiguration and manufacturing

Engineering Contradiction:
Improveimmune response effectivenessVSAvoidvaccine update time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The vaccine performs preliminary action by pre-including antigens from multiple clades and OTUs that are representative of the microbe's diversity. By anticipating potential circulating strains and incorporating their representative antigens in advance, the vaccine eliminates the need for frequent updates and reconfigurations when new strains emerge.

Inventive Principle:
Principle #10Preliminary action

3Adaptability or versatility

If a diverse set of antigens is included to cover multiple clades, then broad immunity is achieved, but the vaccine complexity increases

Engineering Contradiction:
Improvebroad immune coverageVSAvoidvaccine composition complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The vaccine applies local quality by selecting specific antigens with controlled pairwise edit distances (at least 10% but no more than 98% of average antigen size). This ensures that each antigen contributes unique immunogenic information while maintaining appropriate diversity, optimizing broad coverage without unnecessary complexity.

Inventive Principle:
Principle #3Local quality

4Adaptability or versatility

If antigens with large edit distances are selected to represent diverse clades, then strain coverage is maximized, but the immune response may become fragmented

Engineering Contradiction:
Improvestrain coverage breadthVSAvoidimmune response consistency
Core Design Contradiction:
Adaptability or versatilityVSStability of the object's composition

Solution Approach 1:

The vaccine utilizes parameter changes by controlling the pairwise edit distances between antigens within specific ranges (at least 10% but no more than 98% of average antigen size). This parameter optimization ensures antigens are sufficiently diverse to cover multiple strains while maintaining enough similarity to elicit a consistent, unified immune response across all antigen components.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentEP4729125A2Optimized vaccine compositions and methods for making the same
Publication Date: 2026.04.22 CENTIVAX INC
  • EP4729125A2 patent drawingFigure 1
  • EP4729125A2 patent drawingFigure 2
  • EP4729125A2 patent drawingFigure 3

AI summary

Described herein are compositions of and methods of making vaccines which can provide broad serological reactivity an inverse dose response, and a swarm effect.